SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Obesity-related cancer rising among both younger and older adults worldwide, study finds

2.

Future of Lab-Developed Tests Still Taking Shape

3.

Study identifies new approach to protect the brain during radiation therapy

4.

Study finds higher breast cancer rates in areas with more air pollution

5.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot